{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T03:17:44Z","timestamp":1789874264920,"version":"4.0.1"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2022,8,6]],"date-time":"2022-08-06T00:00:00Z","timestamp":1659744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100002160","name":"Jain Foundation","doi-asserted-by":"publisher","award":["NCT01676077"],"award-info":[{"award-number":["NCT01676077"]}],"id":[{"id":"10.13039\/100002160","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,10,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>The North Star Assessment for limb-girdle type muscular dystrophies (NSAD), a clinician-reported outcome measure (ClinRO) of motor performance, was initially developed and validated for use in dysferlinopathy, an autosomal recessive form of limb-girdle muscular dystrophy (LGMD R2\/2B). Recent developments in treatments for limb-girdle muscular dystrophies (LGMD) have highlighted the urgent need for disease-specific ClinROs. The purpose of this study was to understand the ability of the NSAD to quantify motor function across the broad spectrum of LGMD phenotypes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Assessments of 130 individuals with LGMD evaluated by the physical therapy teams at Nationwide Children\u2019s Hospital and the John Walton Muscular Dystrophy Research Centre were included in the analysis. NSAD, 100-m timed test (100MTT), and Performance of Upper Limb 2.0 assessment data were collected. Psychometric analysis with Rasch measurement methods was used to examine the NSAD for suitability and robustness by determining the extent to which the observed data \u201cfit\u201d with predictions of those ratings from the Rasch model. The NSAD score was correlated with the 100MTT and Performance of Upper Limb 2.0 assessment scores for external construct validity.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The NSAD demonstrated a good spread of items covering a continuum of abilities across both individuals who had LGMD and were ambulatory and individuals who had LGMD and were weaker and nonambulatory. Items fit well with the construct measured, validating a summed total score. The NSAD had excellent interrater reliability [intraclass correlation coefficient (ICC)\u2009=\u20090.986, 95% CI\u2009=\u20090.981\u20130.991] and was highly correlated with the 100MTT walk\/run velocity (Spearman rho correlation coefficient of rs(134)\u2009=\u2009.92).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Although LGMD subtypes may differ in age of onset, rate of progression, and patterns of muscle weakness, the overall impact of progressive muscle weakness on motor function is similar. The NSAD is a reliable and valid ClinRO of motor performance for individuals with LGMD and is suitable for use in clinical practice and research settings.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Impact<\/jats:title>\n                  <jats:p>Recent developments in potential pharmacological treatments for LGMD have highlighted the urgent need for disease-specific outcome measures. Validated and meaningful outcome measures are necessary to capture disease presentation, to inform expected rates of progression, and as endpoints for measuring the response to interventions in clinical trials. The NSAD, a scale of motor performance for both individuals who have LGMD and are ambulatory and those who are nonambulatory, is suitable for use in clinical and research settings.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ptj\/pzac113","type":"journal-article","created":{"date-parts":[[2022,8,6]],"date-time":"2022-08-06T15:19:05Z","timestamp":1659799145000},"source":"Crossref","is-referenced-by-count":31,"title":["Validation of the North Star Assessment for Limb-Girdle Type Muscular Dystrophies"],"prefix":"10.1093","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8078-7744","authenticated-orcid":false,"given":"Meredith K","family":"James","sequence":"first","affiliation":[{"name":"Newcastle University and Newcastle Hospitals NHS Foundation Trust The John Walton Muscular Dystrophy Research Centre, , Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2263-7569","authenticated-orcid":false,"given":"Lindsay N","family":"Alfano","sequence":"additional","affiliation":[{"name":"The Abigail Wexner Research Institute at Nationwide Children\u2019s Hospital Center for Gene Therapy, , Columbus, Ohio, USA"},{"name":"The Ohio State University Department of Pediatrics, , Columbus, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Muni-Lofra","sequence":"additional","affiliation":[{"name":"Newcastle University and Newcastle Hospitals NHS Foundation Trust The John Walton Muscular Dystrophy Research Centre, , Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie F","family":"Reash","sequence":"additional","affiliation":[{"name":"The Abigail Wexner Research Institute at Nationwide Children\u2019s Hospital Center for Gene Therapy, , Columbus, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jassi","family":"Sodhi","sequence":"additional","affiliation":[{"name":"Newcastle University and Newcastle Hospitals NHS Foundation Trust The John Walton Muscular Dystrophy Research Centre, , Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan A","family":"Iammarino","sequence":"additional","affiliation":[{"name":"The Abigail Wexner Research Institute at Nationwide Children\u2019s Hospital Center for Gene Therapy, , Columbus, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dionne","family":"Moat","sequence":"additional","affiliation":[{"name":"Newcastle University and Newcastle Hospitals NHS Foundation Trust The John Walton Muscular Dystrophy Research Centre, , Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kianna","family":"Shannon","sequence":"additional","affiliation":[{"name":"The Abigail Wexner Research Institute at Nationwide Children\u2019s Hospital Center for Gene Therapy, , Columbus, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"McCallum","sequence":"additional","affiliation":[{"name":"Newcastle University and Newcastle Hospitals NHS Foundation Trust The John Walton Muscular Dystrophy Research Centre, , Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Richardson","sequence":"additional","affiliation":[{"name":"Newcastle University and Newcastle Hospitals NHS Foundation Trust The John Walton Muscular Dystrophy Research Centre, , Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Eagle","sequence":"additional","affiliation":[{"name":"Newcastle University and Newcastle Hospitals NHS Foundation Trust The John Walton Muscular Dystrophy Research Centre, , Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Straub","sequence":"additional","affiliation":[{"name":"Newcastle University and Newcastle Hospitals NHS Foundation Trust The John Walton Muscular Dystrophy Research Centre, , Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Marini-Bettolo","sequence":"additional","affiliation":[{"name":"Newcastle University and Newcastle Hospitals NHS Foundation Trust The John Walton Muscular Dystrophy Research Centre, , Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda P","family":"Lowes","sequence":"additional","affiliation":[{"name":"The Abigail Wexner Research Institute at Nationwide Children\u2019s Hospital Center for Gene Therapy, , Columbus, Ohio, USA"},{"name":"The Ohio State University Department of Pediatrics, , Columbus, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna G","family":"Mayhew","sequence":"additional","affiliation":[{"name":"Newcastle University and Newcastle Hospitals NHS Foundation Trust The John Walton Muscular Dystrophy Research Centre, , Newcastle upon Tyne, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,8,6]]},"reference":[{"key":"2023083118583883900_ref1","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/brain\/77.2.169","article-title":"On the classification, natural history and treatment of the myopathies","volume":"77","author":"Walton","year":"1954","journal-title":"Brain"},{"key":"2023083118583883900_ref2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0960-8966(93)E0006-G","article-title":"Diagnostic criteria for the limb-girdle muscular dystrophies: report of the ENMC Consortium on Limb-Girdle Dystrophies","volume":"5","author":"Bushby","year":"1995","journal-title":"Neuromuscul Disord"},{"key":"2023083118583883900_ref3","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1469-8749.2011.03939.x","article-title":"Moving towards meaningful measurement: Rasch analysis of the North Star Ambulatory Assessment in Duchenne muscular dystrophy","volume":"53","author":"Mayhew","year":"2011","journal-title":"Dev Med Child Neurol"},{"key":"2023083118583883900_ref4","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S1474-4422(07)70290-9","article-title":"Rating scales as outcome measures for clinical trials in neurology: problems, solutions, and recommendations","volume":"6","author":"Hobart","year":"2007","journal-title":"Lancet Neurol"},{"key":"2023083118583883900_ref5","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1089\/hum.2017.062","article-title":"Systemic delivery of dysferlin overlap vectors provides long-term gene expression and functional improvement for dysferlinopathy","volume":"29","author":"Potter","year":"2018","journal-title":"Hum Gene Ther"},{"key":"2023083118583883900_ref6","article-title":"Systemic gene transfer with rAAVrh74.MHCK7.SGCB increased \u03b2-sarcoglycan expression in patients with limb girdle muscular dystrophy type 2E","volume":"29","author":"Rodino-Klapac","year":"2019","journal-title":"Neuromuscul Disord"},{"key":"2023083118583883900_ref7","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1017\/cjn.2015.311","article-title":"A systematic review and meta-analysis on the epidemiology of the muscular dystrophies","volume":"43","author":"Mah","year":"2016","journal-title":"Can J Neurol Sci"},{"key":"2023083118583883900_ref8","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1038\/s41436-019-0544-8","article-title":"Estimating prevalence for limb-girdle muscular dystrophy based on public sequencing databases","volume":"21","author":"Liu","year":"2019","journal-title":"Genet Med"},{"key":"2023083118583883900_ref9","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1093\/brain\/awp236","article-title":"Prevalence of genetic muscle disease in northern England: in-depth analysis of a muscle clinic population","volume":"132","author":"Norwood","year":"2009","journal-title":"Brain"},{"key":"2023083118583883900_ref10","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.nmd.2018.05.007","article-title":"229th ENMC international workshop: limb girdle muscular dystrophies - nomenclature and reformed classification Naarden, the Netherlands, 17-19 March 2017","volume":"28","author":"Straub","year":"2018","journal-title":"Neuromuscul Disord"},{"key":"2023083118583883900_ref11","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/dmcn.14361","article-title":"Performance of upper limb module for Duchenne muscular dystrophy","volume":"62","author":"Mayhew","year":"2020","journal-title":"Dev Med Child Neurol"},{"key":"2023083118583883900_ref12","volume-title":"Probabilistic Models for Some Intellligence and Attainment Tests","author":"Rasch","year":"1960"},{"key":"2023083118583883900_ref13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3310\/hta13120","article-title":"Improving the evaluation of therapeutic interventions in multiple sclerosis: the role of new psychometric methods","volume":"13","author":"Hobart","year":"2009","journal-title":"Health Technol Assess"},{"key":"2023083118583883900_ref14","doi-asserted-by":"crossref","first-page":"319","DOI":"10.5014\/ajot.47.4.319","article-title":"The assessment of IADL motor skills: an application of many-faceted Rasch analysis","volume":"47","author":"Fisher","year":"1993","journal-title":"Am J Occup Ther"},{"key":"2023083118583883900_ref15","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1002\/ana.26044","article-title":"Assessing dysferlinopathy patients over three years with a new motor scale","volume":"89","author":"Jacobs","year":"2021","journal-title":"Ann Neurol"},{"key":"2023083118583883900_ref16","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000000089","article-title":"The clinical outcome study for dysferlinopathy: an international multicenter study","volume":"2","author":"Harris","year":"2016","journal-title":"Neurol Genet"},{"key":"2023083118583883900_ref17","doi-asserted-by":"crossref","first-page":"S126","DOI":"10.1016\/j.nmd.2018.06.365","article-title":"Clinically meaningful change on the 100 meter timed test in neuromuscular diseases","volume":"28","author":"Alfano","year":"2018","journal-title":"Neuromuscul Disord"},{"key":"2023083118583883900_ref18","first-page":"S145","article-title":"Does the performance of upper limb capture functional variations in dysferlinopathy?","volume":"27","author":"James","year":"2017","journal-title":"Neuromuscul Disord"},{"key":"2023083118583883900_ref19","article-title":"RUMM 2030","author":"RUMMLaboratory"},{"key":"2023083118583883900_ref20","volume-title":"Rating Scale Analysis","author":"Wright","year":"1982"},{"key":"2023083118583883900_ref21","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1023\/B:SOCI.0000025593.97559.7f","article-title":"Measuring subjective health among adolescents in Sweden\u2014a Rasch-analysis of the HBSC\u2014Instrument","volume":"68","author":"Hagquist","year":"2004","journal-title":"Soc Indic Res"},{"key":"2023083118583883900_ref22","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1017\/S0033291700012502","article-title":"The General Health Questionnaire: a psychometric analysis using latent trait theory","volume":"19","author":"Andrich","year":"1989","journal-title":"Psychol Med"},{"key":"2023083118583883900_ref23","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/BF02289113","article-title":"Time-limit tests: estimating their reliability and degree of speeding","volume":"16","author":"Cronbach","year":"1951","journal-title":"Psychometrika"},{"key":"2023083118583883900_ref24","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1191\/026921598672178340","article-title":"Reliability of assessment tools in rehabilitation: an illustration of appropriate statistical analyses","volume":"12","author":"Rankin","year":"1998","journal-title":"Clin Rehabil"},{"key":"2023083118583883900_ref25","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jcm.2016.02.012","article-title":"A guideline of selecting and reporting intraclass correlation coefficients for reliability research","volume":"15","author":"Koo","year":"2016","journal-title":"J Chiropr Med"},{"key":"2023083118583883900_ref26","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2307\/1412107","article-title":"\u201cGeneral intelligence,\u201d objectively determined and measured","volume":"15","author":"Spearman","year":"1904","journal-title":"Am J Psychol"},{"key":"2023083118583883900_ref27","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.nmd.2017.02.007","article-title":"The 100-meter timed test: normative data in healthy males and comparative pilot outcome data for use in Duchenne muscular dystrophy clinical trials","volume":"27","author":"Alfano","year":"2017","journal-title":"Neuromuscul Disord"},{"key":"2023083118583883900_ref28","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1016\/S0140-6736(16)31408-8","article-title":"Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study","volume":"388","author":"Finkel","year":"2016","journal-title":"Lancet"},{"key":"2023083118583883900_ref29","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1111\/dmcn.12220","article-title":"Detecting meaningful change using the North Star Ambulatory Assessment in Duchenne muscular dystrophy","volume":"55","author":"Mayhew","year":"2013","journal-title":"Dev Med Child Neurol"}],"container-title":["Physical Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ptj\/advance-article-pdf\/doi\/10.1093\/ptj\/pzac113\/45289500\/pzac113.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ptj\/article-pdf\/102\/10\/pzac113\/51318200\/pzac113.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ptj\/article-pdf\/102\/10\/pzac113\/51318200\/pzac113.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T18:59:00Z","timestamp":1693508340000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ptj\/article\/doi\/10.1093\/ptj\/pzac113\/6657738"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,6]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10,6]]}},"URL":"https:\/\/doi.org\/10.1093\/ptj\/pzac113","relation":{},"ISSN":["0031-9023","1538-6724"],"issn-type":[{"value":"0031-9023","type":"print"},{"value":"1538-6724","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,10,1]]},"published":{"date-parts":[[2022,8,6]]},"article-number":"pzac113"}}